Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
Overview | Financials
Company Name | Ginkgo Bioworks Holdings, Inc. |
Symbol | DNA |
Currency | USD |
Price | 7.75 |
Market Cap | 430,159,852 |
Dividend Yield | 0% |
52-week-range | 5.26 - 75.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jason Kelly |
Website | https://www.ginkgobioworks.com |
An error occurred while fetching data.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD